imipramine has been researched along with Hyperpigmentation in 11 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To inform clinicians of the potential for severe and persistent facial hyperpigmentation with the long-term use of imipramine." | 8.82 | Imipramine-associated hyperpigmentation. ( Dean, CE; Grund, FM, 2003) |
| "The purpose of this study is to describe the clinical and light microscopic findings in 4 patients with imipramine-induced hyperpigmentation and to better understand its origin." | 8.80 | Imipramine-induced hyperpigmentation: four cases and a review of the literature. ( Bhawan, J; Cohen, LM; McCalmont, TH; Ming, ME; Stefanato, CM, 1999) |
| "Blue or slate-gray hyperpigmentation is seen with a variety of medications, including imipramine." | 7.70 | Laser treatment of imipramine-induced hyperpigmentation. ( Atkin, DH; Fitzpatrick, RE, 2000) |
| "Imipramine is a tricyclic medication that has been used for the treatment of depression and other mood disorders." | 5.46 | Imipramine-induced hyperpigmentation. ( Bicknell, LM; Fernandez, M; McFaddin, CL; Parekh, P, 2017) |
| "We reported a case of photo-distributed hyperpigmentation due to imipramine and carried out a systematic search of the related articles using the search terms "tricyclic antidepressants" or "tricyclic antidepressive agents", and "hyperpigmentation" or "photosensitivity disorder"." | 5.22 | Tricyclic antidepressant-induced photosensitivity; A case report and systematic review. ( Boontaveeyuwat, E; Fityan, A; Mcfadden, JP; Rickaby, W; Sarkany, RPE; Steyn, M, 2022) |
| "To inform clinicians of the potential for severe and persistent facial hyperpigmentation with the long-term use of imipramine." | 4.82 | Imipramine-associated hyperpigmentation. ( Dean, CE; Grund, FM, 2003) |
| "The purpose of this study is to describe the clinical and light microscopic findings in 4 patients with imipramine-induced hyperpigmentation and to better understand its origin." | 4.80 | Imipramine-induced hyperpigmentation: four cases and a review of the literature. ( Bhawan, J; Cohen, LM; McCalmont, TH; Ming, ME; Stefanato, CM, 1999) |
| "We describe a patient with facial pigmentation of 26 years' duration that was associated with imipramine treatment for depression." | 3.73 | Imipramine-induced facial pigmentation: case report and literature review. ( Lin, AN; Metelitsa, AI; Nguyen, GK, 2005) |
| "Blue or slate-gray hyperpigmentation is seen with a variety of medications, including imipramine." | 3.70 | Laser treatment of imipramine-induced hyperpigmentation. ( Atkin, DH; Fitzpatrick, RE, 2000) |
| "Imipramine is a tricyclic medication that has been used for the treatment of depression and other mood disorders." | 1.46 | Imipramine-induced hyperpigmentation. ( Bicknell, LM; Fernandez, M; McFaddin, CL; Parekh, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Coffey, N | 1 |
| Ali, Z | 1 |
| Grau, J | 1 |
| Boontaveeyuwat, E | 1 |
| Steyn, M | 1 |
| Rickaby, W | 1 |
| Mcfadden, JP | 1 |
| Sarkany, RPE | 1 |
| Fityan, A | 1 |
| Bicknell, LM | 1 |
| McFaddin, CL | 1 |
| Fernandez, M | 1 |
| Parekh, P | 1 |
| Izikson, L | 1 |
| Anderson, RR | 1 |
| Dean, CE | 1 |
| Grund, FM | 1 |
| Mendhekar, DN | 1 |
| Metelitsa, AI | 1 |
| Nguyen, GK | 1 |
| Lin, AN | 1 |
| Mehr, N | 1 |
| Wu, JJ | 1 |
| Dyson, SW | 1 |
| Woseth, DM | 1 |
| Ming, ME | 1 |
| Bhawan, J | 1 |
| Stefanato, CM | 1 |
| McCalmont, TH | 1 |
| Cohen, LM | 1 |
| Atkin, DH | 1 |
| Fitzpatrick, RE | 1 |
| Angel, TA | 1 |
| Stalkup, JR | 1 |
| Hsu, S | 1 |
4 reviews available for imipramine and Hyperpigmentation
| Article | Year |
|---|---|
Imipramine-Induced Cutaneous and Iris Hyperpigmentation: A Case Report and Literature Review.
Topics: Antidepressive Agents, Tricyclic; Humans; Hyperpigmentation; Imipramine; Iris; Skin | 2022 |
Tricyclic antidepressant-induced photosensitivity; A case report and systematic review.
Topics: Antidepressive Agents, Tricyclic; Female; Humans; Hyperpigmentation; Imipramine; Photosensitivity Di | 2022 |
Imipramine-associated hyperpigmentation.
Topics: Aged; Humans; Hyperpigmentation; Imipramine; Male | 2003 |
Imipramine-induced hyperpigmentation: four cases and a review of the literature.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Hyperpigmentation; Imipramine; M | 1999 |
7 other studies available for imipramine and Hyperpigmentation
| Article | Year |
|---|---|
Imipramine-induced hyperpigmentation.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Diagnosis, Differential; Face; Female; Humans | 2017 |
Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.
Topics: Aged; Antidepressive Agents, Tricyclic; Female; Hand; Humans; Hyperpigmentation; Imipramine; Lasers, | 2009 |
Imipramine monotherapy-induced Hyperpigmentation in an adolescent girl.
Topics: Adult; Antidepressive Agents, Tricyclic; Biopsy; Depressive Disorder, Major; Diagnosis, Differential | 2005 |
Imipramine-induced facial pigmentation: case report and literature review.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Facial Derm | 2005 |
Imipramine-induced hyperpigmentation of the skin.
Topics: Antidepressive Agents, Tricyclic; Face; Female; Humans; Hyperpigmentation; Imipramine; Middle Aged; | 2007 |
Laser treatment of imipramine-induced hyperpigmentation.
Topics: Aged; Antidepressive Agents, Tricyclic; Beryllium; Female; Humans; Hyperpigmentation; Imipramine; La | 2000 |
Photodistributed blue-gray pigmentation of the skin associated with long-term imipramine use.
Topics: Aged; Antidepressive Agents, Tricyclic; Female; Humans; Hyperpigmentation; Imipramine; Photosensitiv | 2002 |